Document Detail

Lipoteichoic acid induces delayed myocardial protection in isolated rat hearts: a comparison with endotoxin.
MedLine Citation:
PMID:  18635308     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Preconditioning with bacterial wall fragments lipopolysaccharide (LPS) or lipoteichoic acid (LTA) reduce myocardial infarct size after ischaemia and reperfusion (I/R) in rats. Preconditioning with LTA reduces neutrophil accumulation during reperfusion and thereby ameliorates one of myocardial reperfusion injury's most important mechanisms. In this study, we use an ex vivo model of regional myocardial I/R to investigate LTA versus LPS induced preconditioning in a system devoid of leukocytes. METHODS: Rats were subjected to LTA or LPS with or without dexamethasone pre-treatment. Twenty-four hours after LTA or LPS challenge, hearts were removed and retrogradely perfused in a Langendorff set-up. Hearts underwent 20 min of regional ischaemia followed by 2 h of reperfusion. Ischaemic preconditioning (IPC) was performed as a positive control. Myocardial infarct size was determined as the primary end-point. RESULTS: LTA and LPS preconditioning both lead to a marked reduction in infarct size similar to IPC, however, no significant differences were found between LTA and LPS. The reduction in infarct size was abrogated by dexamethasone pre-treatment. CONCLUSION: We conclude that preconditioning with LTA and likewise with LPS confers myocardial protection in an ex vivo setting devoid of leukocytes. Dexamethasone inhibits preconditioning, suggesting that the underlying mechanism is dependent upon induction of a systemic inflammatory response to a LTA or LPS stimulus.
Patrick Schober; Guenther Oprea; Jan Mersmann; Antje Nebert; Kai Zacharowski; Paula A Zacharowski
Related Documents :
8222128 - Ischemic preconditioning fails to limit infarct size in reserpinized rabbit myocardium....
16313758 - mechanism of the protective effects of noninvasive limbs preconditioning on myocardial ...
6691468 - Changes in brain ventricular size with repeated cat scans in suspected alzheimer's dise...
12181158 - Sildenafil (viagra) induces powerful cardioprotective effect via opening of mitochondri...
7933398 - Management of heart failure. i. pharmacologic treatment.
11103178 - Left ventricular pressure-area relations as assessed by transoesophageal echocardiograp...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2008-07-17
Journal Detail:
Title:  Resuscitation     Volume:  79     ISSN:  0300-9572     ISO Abbreviation:  Resuscitation     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-10-27     Completed Date:  2009-02-10     Revised Date:  2009-08-25    
Medline Journal Info:
Nlm Unique ID:  0332173     Medline TA:  Resuscitation     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  311-5     Citation Subset:  IM    
Department of Anaesthesiology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Inflammatory Agents / therapeutic use
Dexamethasone / therapeutic use
Disease Models, Animal
Endotoxins / therapeutic use*
Ischemic Preconditioning, Myocardial / methods*
Lipopolysaccharides / therapeutic use*
Myocardial Infarction / pathology*,  prevention & control*
Rats, Wistar
Systemic Inflammatory Response Syndrome / prevention & control
Teichoic Acids / therapeutic use*
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Endotoxins; 0/Lipopolysaccharides; 0/Teichoic Acids; 50-02-2/Dexamethasone; 56411-57-5/lipoteichoic acid; 67924-63-4/endotoxin, Escherichia coli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Attitudes toward automated external defibrillator use in Japan.
Next Document:  Closing the knowledge-performance gap: an audit of medical management for severe paediatric trauma i...